PAPILLARY RENAL CELL CARCINOMA (PRCC)

Clinical trials for PAPILLARY RENAL CELL CARCINOMA (PRCC) explained in plain language.

Never miss a new study

Get alerted when new PAPILLARY RENAL CELL CARCINOMA (PRCC) trials appear

Sign up with your email to follow new studies for PAPILLARY RENAL CELL CARCINOMA (PRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Drug attack on tough kidney cancers

Disease control Recruiting now

This study is testing a new combination of two drugs, sasanlimab and palbociclib, for people with advanced kidney cancer. The goal is to find a safe and effective dose and to see if the treatment can shrink tumors. It is for adults with specific types of kidney cancer who have li…

Matched conditions: PAPILLARY RENAL CELL CARCINOMA (PRCC)

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

PAPILLARY RENAL CELL CARCINOMA (PRCC)

Get alerted when new PAPILLARY RENAL CELL CARCINOMA (PRCC) trials appear

New Two-Drug attack on tough kidney cancers